2015
DOI: 10.1007/s00066-015-0880-9
|View full text |Cite
|
Sign up to set email alerts
|

Stereotactic LINAC radiosurgery for the treatment of typical intracranial meningiomas

Abstract: Our study emphasizes the efficacy of LINAC-SRS for de novo, residual and recurrent typical intracranial meningiomas. A high long-term local TCR with a low morbidity rate could be achieved. LINAC-SRS should thus be considered as a primary treatment option, as one arm of a combined treatment approach for incompletely resected meningiomas, or as a salvage therapy for recurrences.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
16
1

Year Published

2016
2016
2021
2021

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(21 citation statements)
references
References 42 publications
4
16
1
Order By: Relevance
“…The impact of tumor location on the tumor control was investigated by 4 studies. 18 , 20 , 22 , 33 Two out of these studies 22 , 33 suggest that parafalcine, parasagittal, and convexity locations are significant negative prognostic factors in terms of tumor control, while other 2 studies 18 , 20 did not observe statistical significance.…”
Section: Resultsmentioning
confidence: 98%
See 3 more Smart Citations
“…The impact of tumor location on the tumor control was investigated by 4 studies. 18 , 20 , 22 , 33 Two out of these studies 22 , 33 suggest that parafalcine, parasagittal, and convexity locations are significant negative prognostic factors in terms of tumor control, while other 2 studies 18 , 20 did not observe statistical significance.…”
Section: Resultsmentioning
confidence: 98%
“…The longest reported observation period was 15 yr in one study with a PFS of 89%. 18 Eight- to ten-year PFS rates were reported in 10 studies 12 , 13 , 18 , 21 , 22 , 25 , 27 , 31 , 35 , 36 that evaluated more than 1146 patients, with a PFS rate ranging from 55% to 97% (median, 85.0%). Four- to five-year PFS rates ranged from 74% to 99% (median, 89.4%) in 14 studies, based on more than 1057 patients.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…During the past two decades, SRT has become increasingly well known as a treatment option for meningiomas (16, 17). Adjuvant SRT is offered to all grades II and III meningioma patients, whereas symptomatic grade I meningioma patients only received SRT after incomplete resection.…”
Section: Methodsmentioning
confidence: 99%